Search…

Lates News

15/05/2025

German pharmaceutical company Merck announced that adjusted EBITDA for the first quarter increased by 5.6% to 1.54 billion euros, slightly higher than analysts' expectations of 1.51 billion euros. The company lowered its financial guidance, now expecting full-year adjusted EBITDA to be between 5.8 billion and 6.4 billion euros, lower than last year's 6.07 billion euros, to reflect the weakening US dollar and uncertainty surrounding tariff policies.

Latest

2 m ago

The Nasdaq China Golden Dragon Index fell by an expanded margin, currently down by 3.0% with the latest report at 7302.48 points.

2 m ago

The Nasdaq China Golden Dragon Index extended its decline, falling by 3.0% to 7302.48 points.

2 m ago

Market news: David Sacks is closely watched during talks with Saudi Arabia and the United Arab Emirates.

3 m ago

Shandong Molong: The company's current production and operations are normal, with sufficient orders in hand.

3 m ago

Shandong Molong (002490) replied to investors at the performance briefing on May 15, stating that the company was informed on May 8th and 9th, 2025 that shareholder Zhimeng Holdings and its concerted action parties had reduced their holdings of the company's H shares and promptly fulfilled their disclosure obligations. It was understood that Zhimeng Holdings and its concerted action parties reduced their holdings of H shares mainly for normal trading arrangements for their capital needs. The company's current production and operation are normal with sufficient orders in hand.

See all latest